# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001144204-16-100127
Filing Date
2016-05-10
Accepted
2016-05-10 08:00:31
Documents
18
Period of Report
2016-05-10
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | v439253_8k.htm | 8-K | 13748
2 | EXHIBIT 99.1 | v439253_ex99-1.htm | EX-99.1 | 12221
3 | GRAPHIC | image_001.jpg | GRAPHIC | 5687
4 | GRAPHIC | ex99x1_001.jpg | GRAPHIC | 120569
5 | GRAPHIC | ex99x1_002.jpg | GRAPHIC | 93845
6 | GRAPHIC | ex99x1_003.jpg | GRAPHIC | 105125
7 | GRAPHIC | ex99x1_004.jpg | GRAPHIC | 71786
8 | GRAPHIC | ex99x1_005.jpg | GRAPHIC | 57005
9 | GRAPHIC | ex99x1_006.jpg | GRAPHIC | 60853
10 | GRAPHIC | ex99x1_007.jpg | GRAPHIC | 66332
11 | GRAPHIC | ex99x1_008.jpg | GRAPHIC | 89410
12 | GRAPHIC | ex99x1_009.jpg | GRAPHIC | 64539
13 | GRAPHIC | ex99x1_010.jpg | GRAPHIC | 53682
14 | GRAPHIC | ex99x1_011.jpg | GRAPHIC | 72935
15 | GRAPHIC | ex99x1_012.jpg | GRAPHIC | 62310
16 | GRAPHIC | ex99x1_013.jpg | GRAPHIC | 82607
17 | GRAPHIC | ex99x1_014.jpg | GRAPHIC | 75089
18 | GRAPHIC | ex99x1_015.jpg | GRAPHIC | 65939
| Complete submission text file | 0001144204-16-100127.txt |  | 1609576

Mailing Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108
Business Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108 801 994 7383
Lipocine Inc. (Filer) CIK: 0001535955 (see all company filings)

EIN.: 990370688 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36357 | Film No.: 161633743
SIC: 2834 Pharmaceutical Preparations